These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
965 related articles for article (PubMed ID: 15865609)
1. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E; Erturan Z; Susever S; Yegenoglu Y APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609 [TBL] [Abstract][Full Text] [Related]
2. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit]. Yüksekkaya S; Fındık D; Arslan U Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168 [TBL] [Abstract][Full Text] [Related]
3. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896 [TBL] [Abstract][Full Text] [Related]
4. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613 [TBL] [Abstract][Full Text] [Related]
5. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M; Karaman M Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907 [TBL] [Abstract][Full Text] [Related]
6. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures]. Ozcan SK; Mutlu B; Dündar D; Willke A Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961 [TBL] [Abstract][Full Text] [Related]
8. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780 [TBL] [Abstract][Full Text] [Related]
9. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients. Lombardi G; Gramegna G; Cavanna C; Michelone G Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Ergon MC; Gülay Z Mycoses; 2005 Mar; 48(2):126-31. PubMed ID: 15743431 [TBL] [Abstract][Full Text] [Related]
11. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B. Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333 [TBL] [Abstract][Full Text] [Related]
12. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
13. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT; Velasco D; Canle D; Moure R; Villanueva R Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [TBL] [Abstract][Full Text] [Related]
14. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients. Zer Y; Balci I; Meriç G New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230 [TBL] [Abstract][Full Text] [Related]
15. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system]. Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for candidemia-related mortality at a medical center in central Taiwan. Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249 [TBL] [Abstract][Full Text] [Related]
17. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Yang YL; Li SY; Cheng HH; Lo HJ; Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603 [TBL] [Abstract][Full Text] [Related]
18. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints]. Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300 [TBL] [Abstract][Full Text] [Related]
19. [Identification and susceptibility of clinically isolated yeast-like fungi]. Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256 [TBL] [Abstract][Full Text] [Related]
20. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria. Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]